The Office of the Rosselkhoznadzor for Bashkiria has identified non-compliance with the quality requirements of the "Porcilis ERY" drug produced in the Netherlands. Information about this is available on the website of the supervisory authority.
According to the department, the drug for veterinary use does not pass the “Activity” indicator which is why its sale has been suspended.
Earlier, several more drugs of domestic and foreign production were withdrawn from sale. The Bashinform Agency reported a violation of the quality of the drugs препаратов «Gabivit-Se® (Moscow Region), «Introflor-100 Oral» (Estonia), and others.
Author: Eduard Kuskarbekov